Here is the latest stock price and chart of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
JUST IN: Limited-Time Access to Full Transcript of Our Urgent Broadcast on India's Revival
Live BSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)1,000.60 | Open (Rs) 963.00 | High (Rs) 1,019.00 | Low (Rs) 963.00 |
% Change2.94 | Volume 18,187 | Value (Rs) 18,089,327 | 52-Week H/L 1,150.00 / 600.00 |
Live NSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)1,001.20 | Open (Rs) 972.00 | High (Rs) 1,019.70 | Low (Rs) 965.70 |
% Change2.94 | Volume 417,757 | Value (Rs) 417,395,662 | 52-Week H/L 1,145.00 / 599.15 |
Change | |||||
---|---|---|---|---|---|
1 Day 2.94% | 1 Month 8.30% | 3 Months -6.49% | 1 Year 58.74% | 5 Years (CAGR)* 11.78% | 10 Years (CAGR)* 36.10% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 57.34 | P/E Ratio (x) 17.45 | Market Cap (Rs m) 188,633.11 | P/BV (x) 6.94 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
ALEMBIC PHARMA last traded price was up 2.9% to Rs 1,000.6 on the BSE. On the NSE, ALEMBIC PHARMA last traded price was up 2.9% to Rs 1,001.2. The total volume of shares traded was 0.4 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.9%. And the benchmark S&P BSE SENSEX was at 48,832.0 (up 0.1%).
Over the last 30 days, the ALEMBIC PHARMA share price is up 9.1%. And over the last one year, ALEMBIC PHARMA share price is up 55.9%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.
For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.
Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
This could take India to the position of 3rd largest economy.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More